Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: Preclinical study for treatment of peripheral arterial disease

Gene Therapy

Volumn 8, Issue 3, 2001, Pages 181-189

  Taniyama, Y ^a   Morishita, R ^a,b   Aoki, M ^a   Nakagami, H ^a   Yamamoto, K ^a   Yamazaki, K ^a   Matsumoto, K ^b   Nakamura, T ^b   Kaneda, Y ^b   Ogihara, T ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; Endothelium; Gene therapy; HGF; Peripheral vascular disease

Indexed keywords

LUCIFERASE; PLASMID VECTOR; RECOMBINANT SCATTER FACTOR; SCATTER FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOGRAPHY; ARTERY DISEASE; ARTICLE; BLOOD PRESSURE; CAPILLARY DENSITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; FEASIBILITY STUDY; GENE THERAPY; GENETIC TRANSFECTION; HINDLIMB; LASER DOPPLER FLOWMETRY; LIMB BLOOD FLOW; LIMB ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RABBIT; RAT;

ANIMALS; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEPATOCYTE GROWTH FACTOR; HINDLIMB; HUMANS; ISCHEMIA; LASER-DOPPLER FLOWMETRY; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL VASCULAR DISEASES; RABBITS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 17744388788     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301379     Document Type: Article

References (36)

1. Second European consensus document on chronic critical Leg Ischemia
2. Fate of the patient with chronic leg ischaemia. A review article
3. Suggested standards for reports dealing with lower extremity ischemia
4. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease
5. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
6. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
7. Oncogenic conversion by regulatory changes in transcription factors
8. Vasculogenesis
9. Molecular cloning and expression of human hepatocyte growth factor
10. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure
11. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: Additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor
12. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells
13. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as 'cytokine supplement therapy'
14. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: The case for paracrine amplification of angiogenesis
15. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model
16. Potential role of endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes mellitus
17. Potential role of hepatocyte growth factor in the maintenance of renal structure: Anti-apoptotic action of HGF on epithelial cells
18. Negative regulation of local hepatocyte growth factor (HGF) expression by angiotensin II and transforming growth factor-β in blood vessels: Potential role of HGF in cardiovascular disease
19. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: Down-regulation of HGF in response to hypoxia in vascular cells
20. Efficient in vivo gene transfer into heart in rat myocardial infarction model using HVJ (hemagglutinating virus of Japan)-liposome method
21. The epidemiology of lower extremity amputations in diabetic individuals
22. Critical leg ischaemia: An appraisal of clinical definitions
23. Amputation for occlusive arterial disease. A prospective multicentre study of 177 amputees
24. Late outcomes of limb loss after failed infrainguinal bypass
25. Hepatocyte growth factor (HGF) as tissue organizer for organogenesis and regeneration
26. Emerging multipotent aspects of hepatocyte growth factor
27. Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2
28. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network
29. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction
30. Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo: Evidence that anatomic identification of successful gene transfer may underestimate the of transgene expression
31. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
32. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues
33. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
34. Mouse model of angiogenesis
35. Expression of the Ets-1 proto-oncogene in human gastric carcinoma: Correlation with tumor invasion
36. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene